ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 132 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $222,560 | -40.2% | 10,400 | +13.0% | 0.01% | -44.4% |
| Q1 2023 | $372,048 | +85823.3% | 9,200 | -1.1% | 0.01% | -25.0% |
| Q4 2022 | $433 | -99.9% | 9,300 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $482,000 | +6.2% | 9,300 | +4.5% | 0.01% | +16.7% |
| Q2 2022 | $454,000 | -32.7% | 8,900 | 0.0% | 0.01% | -25.0% |
| Q1 2022 | $675,000 | +3.7% | 8,900 | +2.3% | 0.02% | +14.3% |
| Q4 2021 | $651,000 | +31.8% | 8,700 | 0.0% | 0.01% | +16.7% |
| Q3 2021 | $494,000 | +38.8% | 8,700 | +7.4% | 0.01% | +33.3% |
| Q2 2021 | $356,000 | -11.9% | 8,100 | -1.2% | 0.01% | -18.2% |
| Q1 2021 | $404,000 | +17.1% | 8,200 | 0.0% | 0.01% | +10.0% |
| Q4 2020 | $345,000 | -9.2% | 8,200 | -1.2% | 0.01% | -44.4% |
| Q3 2020 | $380,000 | +71.9% | 8,300 | +88.2% | 0.02% | +38.5% |
| Q2 2020 | $221,000 | -2.6% | 4,410 | 0.0% | 0.01% | -18.8% |
| Q1 2020 | $227,000 | -32.8% | 4,410 | -19.4% | 0.02% | -5.9% |
| Q4 2019 | $338,000 | -4.5% | 5,470 | -7.3% | 0.02% | -10.5% |
| Q3 2019 | $354,000 | -29.2% | 5,900 | 0.0% | 0.02% | -24.0% |
| Q2 2019 | $500,000 | -11.3% | 5,900 | 0.0% | 0.02% | -10.7% |
| Q1 2019 | $564,000 | +35.3% | 5,900 | +0.3% | 0.03% | +16.7% |
| Q4 2018 | $417,000 | -29.3% | 5,881 | -14.8% | 0.02% | -4.0% |
| Q3 2018 | $590,000 | -21.6% | 6,900 | +6.2% | 0.02% | -26.5% |
| Q2 2018 | $753,000 | +45.4% | 6,500 | +1.6% | 0.03% | +41.7% |
| Q1 2018 | $518,000 | +44.7% | 6,400 | +4.9% | 0.02% | +50.0% |
| Q4 2017 | $358,000 | +32.1% | 6,100 | +5.2% | 0.02% | +23.1% |
| Q3 2017 | $271,000 | +32.2% | 5,800 | +1.8% | 0.01% | +30.0% |
| Q2 2017 | $205,000 | -2.4% | 5,700 | -1.7% | 0.01% | -9.1% |
| Q3 2015 | $210,000 | – | 5,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |